Trial Profile
The Use of Statins for Myocardial Death Prevention: From Cell to Bedside.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Myocardial infarction
- Focus Pharmacodynamics
- 25 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 May 2012 Actual patient number added 25 according to ClinicalTrials.gov.
- 08 Nov 2008 New trial record.